Clinical trial
Association of FC-Gamma Receptor Genotypes With Response and Clinical Benefit With Addition of Rituximab to CHOP Chemotherapy in Patients With Follicular Lymphoma (FL)
NCT00933127 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Association of FC-Gamma Receptor Genotypes With Response and Clinical Benefit With Addition of Rituximab to CHOP Chemotherapy in Patients With Follicular Lymphoma (FL)
- Lead sponsor
- SWOG Cancer Research Network
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2008
- Completion date
- June 30, 2012
- Enrollment
- 142 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.